Search clinical trials for: GnRH agonist

Total 14603 results

Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Active, not recruiting

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Prostate Cancer

United States, Canada
Clínica EUGIN

Completed

Ovarian Response in Oocyte Donors Triggered With GnRH Agonists

Poor Response to Ovulation Induction

Spain
Royan Institute

Completed

Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Iran, Islamic Republic of
University Hospital, Toulouse

Withdrawn

Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis (ADENOFIV)

Adenomyosis

France
M.D. Anderson Cancer Center

Completed

Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer

Prostate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8

United States
Shaare Zedek Medical Center

Active, not recruiting

GnRH Agonist for Luteal Phase Support.

Use of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF Cycles

Israel
Sheba Medical Center

Completed

Follicle Size and Oocyte Development (AMJH)

IVF Treatment

Israel
Sheba Medical Center

Completed

IVF Treatment in Women With Immature Oocytes in Previous Cycle

Infertility

Israel
Mount Sinai Hospital, Canada

Completed

Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation

Infertility

Canada
National Institute of Mental Health (NIMH)

Completed

The Effects of Reproductive Hormones on Mood and Behavior

Healthy Volunteers

United States
Takeda

Completed

A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants

Central Precocious Puberty

China
Organon and Co

Completed

Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)(Study 38644)(P05966)(COMPLETED)

Pregnancy | Neonates
Organon and Co

Completed

A Trial of Single Dose Corifollitropin Alfa's Ability to Induce Multiple Follicular Growth During the First Week of Controlled Ovarian Stimulation for IVF or ICSI (38833)(P05788) (Realize)

In Vitro Fertilization
Tehran University of Medical Sciences

Completed

GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes

Polycystic Ovary Syndrome | Infertility, Female

Iran, Islamic Republic of
Kuban State Medical University

Active, not recruiting

Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a

Infertility

Russian Federation
Colorado Center for Reproductive Medicine

Completed

Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF (IntegrinIVF)

Infertility | Endometriosis

United States
AZ Jan Palfijn Gent
Onze Lieve Vrouw Hospital

Completed

Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients

Infertility | PCOS

Belgium
Peter Humaidan

Completed

The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients (GnRHa trigger)

Infertility

Denmark
San Carlo Public Hospital, Potenza, Italy

Completed

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

Ovarian Hyperstimulation Syndrome

Italy
Baylor College of Medicine
Eli Lilly and Company; TAP Pharmaceutical Products Inc.

Terminated

Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism

Hypothyroidism

United States
Create Fertility Center

Unknown

Efficacy and Safety of Medication Used to Stimulate Ovulation

Pregnancy | Ovarian Stimulation | Miscarriages | IVF Cycle | Egg Retrieval | Ovarian Hyperstimulation

Canada
Peter Humaidan

Completed

Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation

Frozen Embryo Transfer | Pregnancy Loss

Denmark
Alkü Alanya Education and Research Hospital

Unknown

PREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERİN FIBROIDS

Uterine Fibroid | Gonadotropin-Releasing Hormone-Dependent Precocious Puberty

Turkey
Riyadh Fertility and Reproductive Health center

Unknown

Double Trigger in Patients With Low Proportion of Mature Oocytes

Infertility, Female

Egypt
Riyadh Fertility and Reproductive Health center

Unknown

Double Trigger in Patients With Low Number of Oocytes Retrieved Per Number of Preovulatory Follicles

Infertility, Female

Egypt
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Novartis Pharmaceuticals; Eastern Cooperative... and other collaborators

Completed

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Prostate Cancer | Metastatic Cancer

United States, Canada
Ipsen

Completed

Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy (PRISME)

Prostate Cancer

France
Assistance Publique - Hôpitaux de Paris

Unknown

Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer (PRESOV)

Sarcoma | Lymphoma | Cancer | Osteosarcoma | Ewing Sarcoma | Toxicity Due to Chemotherapy

France
National Institute of Mental Health (NIMH)

Completed

Combined Hormone Replacement in Menstrually-Related Mood Disorders

Depression | Premenstrual Syndrome

United States
Rabin Medical Center
Ferring Pharmaceuticals

Unknown

Cardiovascular Events in GnRH Agonist vs. Antagonist

Prostate Cancer | Cardiac Event | Hormone Sensitive Prostate Cancer

Israel
National University of Malaysia

Completed

Luteal Phase Support In IVF Women Using GnRH Agonist

Luteal Phase Defect | IVF

Malaysia
University of Colorado, Denver
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Females, Aging, Metabolism, and Exercise (FAME)

Obesity

United States
Peking University Third Hospital
Merck Serono GmbH, Germany; Fountain Medical Development Co., Ltd.; Guangzhou...

Unknown

To Investigate the Cumulative Live Birth Rates Using GnRH Antagonist or Agonist Protocol for COS in ART Treatment (CLBR)

Sterility

China
University Hospital, Lille

Terminated

Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response (COAGO)

Ovarian Hyperstimulation Syndrome | Hypercoagulability
University of Oregon
National Institute on Aging (NIA); Oregon Health and Science University; University... and other collaborators

Unknown

Mechanistic Approach to Preventing Atrophy and Restoring Function in Older Adults

Quality of Life | Muscle Atrophy

United States
Instituto Bernabeu

Terminated

Random-start Ovarian Stimulation in Egg-donors (ROSE) (ROSE)

Infertility

Spain
Cairo University

Completed

Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles

Assisted Reproduction

Egypt
Maimonides Medical Center

Withdrawn

GnRH Agonist at Embryo Transfer: IVF Outcomes (GRAET)

Infertility | Infertility, Female | Infertility, Male

United States
Samsung Medical Center

Unknown

A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC

Metastatic Breast Cancer

Korea, Republic of
New Hope Fertility Center

Completed

Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization

Infertility

United States
Istituto Clinico Humanitas

Completed

RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER

GnRH Trigger and Rescue Protocol
Hue University of Medicine and Pharmacy

Completed

GnRH Agonist Versus hCG Trigger in Ovulation Induction With Intrauterine Insemination.

Ovulation Induction
University of California, San Francisco

Terminated

The Relation of GnRH Treatment to QTc Interval in Transgender Females

Gender Dysphoria

United States
Royan Institute

Completed

Outcome of Two Protocols in Poor Responders in Assisted Reproductive Technology (ART) Cycle

Infertility

Iran, Islamic Republic of
UConn Health
Schering-Plough

Terminated

Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

Ovarian Hyperstimulation Syndrome | Endometrial Receptivity

United States
UConn Health
Merck Sharp & Dohme LLC

Completed

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

Ovarian Hyperstimulation Syndrome

United States
Cairo University

Unknown

Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment

Invitro Fertilization

Egypt
Cairo University

Unknown

Comparative Study Between ICSI Results in Transvaginal Ultrasound Guided Embryo Transfer and Transabdominal Ultrasound Guided Embryo Transfer

Invitro Fertilization

Egypt
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma

Mycosis Fungoides | Recurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Anaplastic Large Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated... and other conditions

United States
Kasr El Aini Hospital

Completed

Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients (GnRh)

Endometrioma

Egypt

Search clinical trials for: GnRH agonist

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations